Literature DB >> 32025823

Extremity Soft Tissue Sarcoma: Role of Local Control.

Elyse J Brinkmann1, Safia K Ahmed2, Matthew T Houdek3.   

Abstract

OPINION STATEMENT: For localized extremity soft tissue sarcoma (eSTS), treatment is individualized and each patient needs to be evaluated by a multidisciplinary team at a referral sarcoma center specialized in the care of sarcoma. For a majority of patients, treatment for eSTS involves limb-salvage surgery, with or without the addition of radiation therapy. Surgery should only be performed by surgeons specifically fellowship trained in the resection of eSTS. Surgery alone may be considered for small, low-grade, and superficial tumors as long a wide (≥ 2 cm) margin can be achieved. In cases where a less than wide negative margin can be achieved, radiation therapy should be utilized to facilitate a planned close margin resection to preserve critical structures (such as nerves, blood vessels, and bone) without a significant impact on oncologic outcomes. Soft tissue sarcomas are rare, and as such patients often present following an inadvertent excision. In these situations, we recommend preoperative radiation and wide tumor bed re-excision, as rates of residual tumor can be high in this scenario. While there is large amount of evidence to support the use of radiotherapy to enhance local tumor control, the evidence to support the use of chemotherapy to enhance local tumor control is lacking, and as such cannot be recommended for all patients.

Entities:  

Keywords:  Adjuvant radiotherapy; Limb-salvage surgery; Neoadjuvant radiotherapy; Soft tissue sarcoma

Mesh:

Year:  2020        PMID: 32025823     DOI: 10.1007/s11864-020-0703-9

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  69 in total

Review 1.  Innovative radiotherapy of sarcoma: Proton beam radiation.

Authors:  Thomas F DeLaney; Rick L M Haas
Journal:  Eur J Cancer       Date:  2016-05-31       Impact factor: 9.162

2.  Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity.

Authors:  Michael R Folkert; Samuel Singer; Murray F Brennan; Deborah Kuk; Li-Xuan Qin; Wendy K Kobayashi; Aimee M Crago; Kaled M Alektiar
Journal:  J Clin Oncol       Date:  2014-09-02       Impact factor: 44.544

Review 3.  Refinements in Sarcoma Classification in the Current 2013 World Health Organization Classification of Tumours of Soft Tissue and Bone.

Authors:  Vickie Y Jo; Leona A Doyle
Journal:  Surg Oncol Clin N Am       Date:  2016-07-30       Impact factor: 3.495

4.  Fractures following radiotherapy and limb-salvage surgery for lower extremity soft-tissue sarcomas. A comparison of high-dose and low-dose radiotherapy.

Authors:  Ginger E Holt; Anthony M Griffin; Melania Pintilie; Jay S Wunder; Charles Catton; Brian O'Sullivan; Robert S Bell
Journal:  J Bone Joint Surg Am       Date:  2005-02       Impact factor: 5.284

5.  Extremity soft tissue sarcoma: adding to the prognostic meaning of local failure.

Authors:  Alessandro Gronchi; Rosalba Miceli; Marco Fiore; Paola Collini; Laura Lozza; Federica Grosso; Luigi Mariani; Paolo G Casali
Journal:  Ann Surg Oncol       Date:  2007-01-28       Impact factor: 5.344

6.  Development of a measure of physical function for patients with bone and soft tissue sarcoma.

Authors:  A M Davis; J G Wright; J I Williams; C Bombardier; A Griffin; R S Bell
Journal:  Qual Life Res       Date:  1996-10       Impact factor: 4.147

7.  Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients.

Authors:  P Gustafson; K E Dreinhöfer; A Rydholm
Journal:  Acta Orthop Scand       Date:  1994-02

Review 8.  Radiation-induced sarcoma.

Authors:  S R Patel
Journal:  Curr Treat Options Oncol       Date:  2000-08

9.  Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.

Authors:  Peter W M Chung; Benjamin M Deheshi; Peter C Ferguson; Jay S Wunder; Anthony M Griffin; Charles N Catton; Robert S Bell; Lawrence M White; Rita A Kandel; Brian O'Sullivan
Journal:  Cancer       Date:  2009-07-15       Impact factor: 6.860

10.  Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.

Authors:  Penella J Woll; Peter Reichardt; Axel Le Cesne; Sylvie Bonvalot; Alberto Azzarelli; Harald J Hoekstra; Michael Leahy; Frits Van Coevorden; Jaap Verweij; Pancras C W Hogendoorn; Monia Ouali; Sandrine Marreaud; Vivien H C Bramwell; Peter Hohenberger
Journal:  Lancet Oncol       Date:  2012-09-04       Impact factor: 41.316

View more
  2 in total

1.  The Impact of Unplanned Excision on the Outcomes of Patients With Soft Tissue Sarcoma of the Trunk and Extremity: A Propensity Score Matching Analysis.

Authors:  Yao Liang; Tian-Hui Guo; Bu-Shu Xu; Dong-Chun Hong; Hai-Bo Qiu; Zhi-Wei Zhou; Xing Zhang
Journal:  Front Oncol       Date:  2021-01-22       Impact factor: 6.244

2.  Free Functional Latissimus Dorsi Reconstruction of the Quadriceps and Hamstrings following Oncologic Resection of Soft Tissue Sarcomas of the Thigh.

Authors:  Matthew T Houdek; Elizabeth P Wellings; Katherine E Mallett; Rachel L Honig; Peter S Rose; Steven L Moran
Journal:  Sarcoma       Date:  2021-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.